These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9076645)

  • 41. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
    Speroff L
    Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oestrogen therapy for the menopause.
    Studd J; Watson N; Henderson A
    Br J Psychiatry; 1990 Dec; 157():931-2. PubMed ID: 2289110
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of menopausal women seeking assistance.
    Anderson E; Hamburger S; Liu JH; Rebar RW
    Am J Obstet Gynecol; 1987 Feb; 156(2):428-33. PubMed ID: 3826179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life during sequential hormone replacement therapy -- a placebo-controlled study.
    Derman RJ; Dawood MY; Stone S
    Int J Fertil Menopausal Stud; 1995; 40(2):73-8. PubMed ID: 7599662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study.
    Collins A; Landgren BM
    Maturitas; 1994 Dec; 20(2-3):101-11. PubMed ID: 7715461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience of climacteric symptoms among 42-46 and 52-56-year-old women.
    Jokinen K; Rautava P; Mäkinen J; Ojanlatva A; Sundell J; Helenius H
    Maturitas; 2003 Nov; 46(3):199-205. PubMed ID: 14585522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.
    Bech P; Munk-Jensen N; Obel EB; Ulrich LG; Eiken P; Nielsen SP
    Psychother Psychosom; 1998; 67(4-5):259-65. PubMed ID: 9693354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
    Paoletti AM; Cagnacci A; Di Carlo C; Orrù MM; Neri M; D'Alterio MN; Melis GB
    Gynecol Endocrinol; 2015 May; 31(5):384-7. PubMed ID: 25703254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral oestrogen replacement therapy versus placebo for hot flushes.
    MacLennan A; Lester S; Moore V
    Cochrane Database Syst Rev; 2001; (1):CD002978. PubMed ID: 11279791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuation of hormone replacement therapy in Slovenia: a prospective, randomized, controlled trial--1-year follow-up.
    Franić D; Verdenik I; Meden-Vrtovec H; Svab I
    Maturitas; 2006 May; 54(2):110-8. PubMed ID: 16293377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
    Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
    Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the quality of life of women in the climacteric period].
    Skrzypulec V; Drosdzol A; Ferensowicz J
    Ginekol Pol; 2004 May; 75(5):373-81. PubMed ID: 15524411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.